AMY HEIDELBERG: Open Payments
NPI 1982165080 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,772 in 92 payments from 16 companies in 2025. Trend: 2023 $1,209 · 2024 $1,330 · 2025 $1,772
Food & beverage: $1,640Education: $132
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $302 |
| GENZYME CORPORATION | 8 | $273 |
| Novartis Pharmaceuticals Corporation | 17 | $242 |
| ABBVIE INC. | 8 | $169 |
| E.R. Squibb & Sons, L.L.C. | 7 | $147 |
| Arcutis Biotherapeutics, Inc. | 13 | $143 |
| Regeneron Healthcare Solutions, Inc. | 4 | $103 |
| Janssen Biotech, Inc. | 2 | $88 |
| Botanix SB Inc | 3 | $70 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $51 |
Products named: DUPIXENT, Bimzelx, COSENTYX, Sotyktu, Zoryve, SKYRIZI, TREMFYA, SOFDRA.
Industry payments across MS — which companies pay providers there.
